Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

NextCure, Inc. (NXTC) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/14/2023 EFFECT Form EFFECT - Notice of Effectiveness:
08/04/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
08/04/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
07/19/2023 8-K Quarterly results
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
03/02/2023 10-K Annual Report for the period ended December 31, 2022
03/02/2023 8-K Quarterly results
03/01/2023 4 Mayer Timothy (COO) has filed a Form 4 on NextCure, Inc.
Txns: Granted 135,000 options to buy @ $1.55, valued at $209.3k
03/01/2023 4 Kundu Sourav (Sr VP, Dev. & Mfg.) has filed a Form 4 on NextCure, Inc.
Txns: Granted 75,000 options to buy @ $1.55, valued at $116.3k
03/01/2023 4 Myint Han (Chief Medical Officer) has filed a Form 4 on NextCure, Inc.
Txns: Granted 135,000 options to buy @ $1.55, valued at $209.3k
03/01/2023 4 Shaw Kevin G. (Sr VP, Legal Affairs) has filed a Form 4 on NextCure, Inc.
Txns: Granted 75,000 options to buy @ $1.55, valued at $116.3k
03/01/2023 4 Langermann Sol (Chief Scientific Officer) has filed a Form 4 on NextCure, Inc.
Txns: Granted 135,000 options to buy @ $1.55, valued at $209.3k
03/01/2023 4 Richman Michael (President & CEO) has filed a Form 4 on NextCure, Inc.
Txns: Granted 309,000 options to buy @ $1.55, valued at $479k
03/01/2023 4 Cobourn Steven P. (CFO) has filed a Form 4 on NextCure, Inc.
Txns: Granted 135,000 options to buy @ $1.55, valued at $209.3k
02/28/2023 3 Shaw Kevin G. (Sr VP, Legal Affairs) has filed a Form 3 on NextCure, Inc.
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/24/2023 SC 13G MILLENNIUM MANAGEMENT LLC reports a 5.2% stake in NEXTCURE, INC.
11/03/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/03/2022 8-K Quarterly results
08/04/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Quarterly results
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Borgman Anne Elizabeth (Director) has filed a Form 4 on NextCure, Inc.
Txns: Granted 14,250 options to buy @ $4.77, valued at $68k
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/23/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy